검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-8 · 마지막 7월 21일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Bacillus Calmette Guerin Vaccine (Bacillus Calmette Guerin Vaccine) Serum Life Science Europe GmbH·Non-muscle Invasive Bladder Cancer 56 trials |
|---|---|
Overview Program | Bacillus Calmette Guerin Vaccine |
Overview Company | Serum Life Science Europe GmbH |
Overview Modality | ADC |
Overview Target | Non-muscle Invasive Bladder Cancer |
Overview Indication | Non-muscle Invasive Bladder Cancer; HER-2 Protein Overexpression |
Overview Phase | PHASE_2 |
Overview Status | RECRUITING |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse |
PK/PD Experiment | PD |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse |
Toxicology Major finding | Molecular Cloning and In silico Epitope Prediction of Culture Filtrate Protein 10 and Resuscitation-promoting Factor D from Mycobacterium tuberculosis with Potential Immunodiagnostic Applications.. Tuberculosis (TB) is regarded as one of the most challenging infectious diseases globally, posing significant obstacles in terms of diagnosis and treatment. The limited effectiveness of the Bacillus Cal… |
Clinical OS | 0.96 |
Clinical Result source | ClinicalTrials.gov NCT04172675 |
Clinical Data Tier / Score | A · 38 |
Clinical Program phase | PHASE_2 |
Clinical Clinical sync | 2026년 7월 18일 (8일 전) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-8 · 마지막 7월 21일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Bacillus Calmette Guerin Vaccine (Bacillus Calmette Guerin Vaccine) Serum Life Science Europe GmbH·Non-muscle Invasive Bladder Cancer 56 trials |
|---|---|
Overview Program | Bacillus Calmette Guerin Vaccine |
Overview Company | Serum Life Science Europe GmbH |
Overview Modality | ADC |
Overview Target | Non-muscle Invasive Bladder Cancer |
Overview Indication | Non-muscle Invasive Bladder Cancer; HER-2 Protein Overexpression |
Overview Phase | PHASE_2 |
Overview Status | RECRUITING |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse |
PK/PD Experiment | PD |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse |
Toxicology Major finding | Molecular Cloning and In silico Epitope Prediction of Culture Filtrate Protein 10 and Resuscitation-promoting Factor D from Mycobacterium tuberculosis with Potential Immunodiagnostic Applications.. Tuberculosis (TB) is regarded as one of the most challenging infectious diseases globally, posing significant obstacles in terms of diagnosis and treatment. The limited effectiveness of the Bacillus Cal… |
Clinical OS | 0.96 |
Clinical Result source | ClinicalTrials.gov NCT04172675 |
Clinical Data Tier / Score | A · 38 |
Clinical Program phase | PHASE_2 |
Clinical Clinical sync | 2026년 7월 18일 (8일 전) |
추천 비교
추천 비교